Wood, P. J., Strong, R., McArthur, G. A., Michael, M., Algar, E., Muscat, A., … Ashley, D. M. (2014). A phase I study of panobinostat in pediatric patients with refractory solid tumors, including CNS tumors. In Journal of Clinical Oncology (Vol. 32, pp. 10061–10061). American Society of Clinical Oncology (ASCO). https://doi.org/10.1200/jco.2014.32.15_suppl.10061

Wood, Paul James, Robyn Strong, Grant A. McArthur, Michael Michael, Elizabeth Algar, Andrea Muscat, Lin Rigby, and David M. Ashley. “A phase I study of panobinostat in pediatric patients with refractory solid tumors, including CNS tumors.” In Journal of Clinical Oncology, 32:10061–10061. American Society of Clinical Oncology (ASCO), 2014. https://doi.org/10.1200/jco.2014.32.15_suppl.10061.

Wood PJ, Strong R, McArthur GA, Michael M, Algar E, Muscat A, et al. A phase I study of panobinostat in pediatric patients with refractory solid tumors, including CNS tumors. In: Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2014. p. 10061–10061.

Wood, Paul James, et al. “A phase I study of panobinostat in pediatric patients with refractory solid tumors, including CNS tumors.” Journal of Clinical Oncology, vol. 32, no. 15_suppl, American Society of Clinical Oncology (ASCO), 2014, pp. 10061–10061. Crossref, doi:10.1200/jco.2014.32.15_suppl.10061.

Wood PJ, Strong R, McArthur GA, Michael M, Algar E, Muscat A, Rigby L, Ashley DM. A phase I study of panobinostat in pediatric patients with refractory solid tumors, including CNS tumors. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2014. p. 10061–10061.